journal article·2024

Effect of ligand and shell densities on the surface structure of core–shell nanoparticles self-assembled from function–spacer–lipid constructs

Ivan Vaskan, Veronika Dimitreva, Maxim Petoukhov, Eleonora Shtykova, Nicolai Bovin, Alexander Tuzikov, Marina Tretyak, Vladimir Oleinikov, Anton Zalygin

Biomaterials Science· Volume 12· Issue 3
Publisher page

Abstract

Biomolecular corona is the major obstacle to the clinical translation of nanomedicines. Since corona formation is governed by molecular interactions at the nano-bio interface, nanoparticle surface properties such as topography, charge and surface chemistry can be tuned to manipulate biomolecular corona formation. To this end, as the first step towards a deep understanding of the processes of corona formation, it is necessary to develop nanoparticles employing various biocompatible materials and characterize their surface structure and dynamics at the molecular level. In this work, we applied molecular dynamics simulation to study the surface structure of organic core-shell nanoparticles formed by the self-assembly of synthetic molecules composed of a DOPE lipid, a carboxymethylglycine spacer and biotin. Lipid moieties form the hydrophobic core, spacer motifs serve as a hydrophilic shell and biotin residues function as a targeting ligand. By mixing such function-spacer-lipid, spacer-lipid and lipid-only constructs at various molar ratios, densities of the ligand and spacer on the nanoparticle surface were modified. For convenient analysis of the structure and dynamics of all regions of the nanoparticle surface, we compiled topography maps based on atomic coordinates. It was shown that an increase in the density of the shell does not reduce exposure of the core, but increases shell average thickness. Biotin, due to its alkyl valeric acid chain and spacer flexibility, is localized primarily near the hydrophobic core and its partial presentation on the surface occurs only in nanoparticles with higher ligand densities. However, an increase in biotin density leads to its clustering. In turn, ligand clustering diminishes the stealth properties of the shell and targeting efficiency. Based on nanoparticle surface structures, we determined the optimal density of biotin. Experimental studies reported in the literature confirm these conclusions. We also suggest design tips to achieve the preferred biotin presentation. Simulation results are consistent with the synchrotron SAXS profile. We believe that such studies will contribute to a better understanding of nano-bio interactions towards the rational design of efficient drug delivery systems.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanopore and Nanochannel Transport Studies · Microfluidic and Capillary Electrophoresis Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia

National Research Nuclear University Moscow Engineering Physics Institute, Moscow, 115409, Russia

A.V. Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics” of the Russian Academy of Sciences, Moscow, 119333, Russia

A.N. Frumkin Institute of Physical Chemistry and Electrochemistry of Russian Academy of Sciences, Moscow, 119071, Russia

Funding

Russian Science Foundation

References (45)

Show source-provided references
1. Shi · Nat. Rev. Cancer · 2017 · 17 · 2010.1038/nrc.2016.108 ↗
2. Wilhelm · Nat. Rev. Mater. · 2016 · 1 · 110.1038/natrevmats.2016.14 ↗
3. Nienhaus · Mater. Today Adv. · 2020 · 5 · 10003610.1016/j.mtadv.2019.100036 ↗
4. S.Tenzer , et al. , Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology , in Nano-enabled medical applications , Jenny Stanford Publishing , 2020 , pp. 251–278
5. Klepac · Nanoscale · 2018 · 10 · 619410.1039/C7NR09355A ↗
6. Alberg · Small · 2020 · 16 · 190757410.1002/smll.201907574 ↗
7. Docter · Chem. Soc. Rev. · 2015 · 44 · 609410.1039/C5CS00217F ↗
8. Debayle · Biomaterials · 2019 · 219 · 11935710.1016/j.biomaterials.2019.119357 ↗
9. Schroffenegger · ACS Nano · 2020 · 14 · 1270810.1021/acsnano.0c02358 ↗
10. Hollingsworth · Neuron · 2018 · 99 · 112910.1016/j.neuron.2018.08.011 ↗
11. Mitchell · Nat. Rev. Drug Discovery · 2021 · 20 · 10110.1038/s41573-020-0090-8 ↗
12. Sen · Chem. Soc. Rev. · 2018 · 47 · 384910.1039/C8CS00022K ↗
13. Vukovic · J. Am. Chem. Soc. · 2011 · 133 · 1348110.1021/ja204043b ↗
14. Pearson · ACS Nano · 2016 · 10 · 690510.1021/acsnano.6b02708 ↗
15. Cedervall · Proc. Natl. Acad. Sci. U. S. A. · 2007 · 104 · 205010.1073/pnas.0608582104 ↗
16. Mirsadeghi · Nanoscale · 2015 · 7 · 500410.1039/C4NR06009A ↗
17. Paula · ACS Appl. Mater. Interfaces · 2014 · 6 · 343710.1021/am405594q ↗
18. Bilardo · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2022 · 14 · e1788
19. Lundqvist · Proc. Natl. Acad. Sci. U. S. A. · 2008 · 105 · 1426510.1073/pnas.0805135105 ↗
20. Lynch · Nano Today · 2008 · 3 · 4010.1016/S1748-0132(08)70014-8 ↗
21. Boldon · Nano Rev. · 2015 · 6 · 2566110.3402/nano.v6.25661 ↗
22. Heathcote · Transfusion · 2010 · 50 · 63510.1111/j.1537-2995.2009.02480.x ↗
23. Hadac · J. Virol. Methods · 2011 · 176 · 7810.1016/j.jviromet.2011.06.005 ↗
24. Lan · J. Fluoresc. · 2012 · 22 · 105510.1007/s10895-012-1043-3 ↗
25. Oliver · Transfusion · 2011 · 51 · 172310.1111/j.1537-2995.2010.03034.x ↗
26. Tretiakova · Colloids Surf., B · 2018 · 166 · 4510.1016/j.colsurfb.2018.02.061 ↗
27. Zalygin · ChemistryOpen · 2020 · 9 · 64110.1002/open.201900276 ↗
28. Vaskan · Colloids Surf., B · 2023 · 224 · 11318310.1016/j.colsurfb.2023.113183 ↗
29. Song · Biomaterials · 2018 · 180 · 7810.1016/j.biomaterials.2018.07.006 ↗
30. Abstiens · ACS Appl. Mater. Interfaces · 2018 · 11 · 131110.1021/acsami.8b18843 ↗
31. Sivaram · ACS Nano · 2020 · 14 · 1373910.1021/acsnano.0c06033 ↗
32. Maslanka Figueroa · Macromol. Biosci. · 2020 · 20 · 190042710.1002/mabi.201900427 ↗
33. Henry · Sci. Rep. · 2018 · 8 · 284510.1038/s41598-018-21186-3 ↗
34. Blanchet · J. Appl. Crystallogr. · 2015 · 48 · 43110.1107/S160057671500254X ↗
35. Jeffries · J. Synchrotron Radiat. · 2015 · 22 · 27310.1107/S1600577515000375 ↗
36. Franke · J. Appl. Crystallogr. · 2017 · 50 · 121210.1107/S1600576717007786 ↗
37. L. A.Feigin and D. I.Svergun , Structure analysis by small-angle X-ray and neutron scattering , Plenum Press , New York , 1987 , vol. 110.1007/978-1-4757-6624-0 ↗
38. Stroet · J. Chem. Theory Comput. · 2018 · 14 · 583410.1021/acs.jctc.8b00768 ↗
39. Humphrey · J. Mol. Graphics · 1996 · 14 · 3310.1016/0263-7855(96)00018-5 ↗
40. Svergun · J. Appl. Crystallogr. · 1995 · 28 · 76810.1107/S0021889895007047 ↗
41. Eisenhaber · J. Comput. Chem. · 1995 · 16 · 27310.1002/jcc.540160303 ↗
42. A. V.Kabanov and V. YuAlakhov , Pluronic® block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers , in Critical Reviews™ in Therapeutic Drug Carrier Systems , 2002 , vol. 19 1
43. Jurczyk · Pharmaceutics · 2021 · 13 · 32610.3390/pharmaceutics13030326 ↗
44. Partikel · Eur. J. Pharm. Biopharm. · 2019 · 141 · 7010.1016/j.ejpb.2019.05.006 ↗
45. Simonelli · J. Phys. Chem. B · 2019 · 123 · 176410.1021/acs.jpcb.8b11204 ↗